RIP2 kinase inhibitor 1 10mg
-
Catalog numberCS-5912-10mg
-
PricePlease ask
-
Size10mg
-
-
Alternative_NamesNA
-
CAS1423186-80-4
-
Purity>98%
-
MWt458.55
-
FormulaC21H22N4O4S2
-
SolubilityDMSO : ≥ 32 mg/mL (69.79 mM)
-
Clinical_InformationNo Development Reported
-
PathwayApoptosis
-
TargetRIP kinase
-
DescriptionTissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Gene symbolARHGEF28, RIPK2
-
Short nameRIP2 kinase inhibitor 1 10mg
-
Alternative nameRIP2 phosphorylation catalyst suppressor 1 10mg
-
Gene info
-
Identity
-
Gene
-
Long gene nameRho guanine nucleotide exchange factor 28
-
Synonyms gene name
- Rho guanine nucleotide exchange factor (GEF) 28
-
Synonyms
-
Locus
-
Discovery year2012-08-08
-
Entrez gene record
-
Pubmed identfication
-
Classification
- Dbl family Rho GEFs
-
VEGA ID
Gene info
-
Identity
-
Gene
-
Long gene namereceptor interacting serine/threonine kinase 2
-
Synonyms gene name
- receptor-interacting serine-threonine kinase 2
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1999-05-07
-
Entrez gene record
-
Pubmed identfication
-
Classification
- Caspase recruitment domain containing
-
VEGA ID
